Microbial burden assessment of solid pharmaceutical products
European Pharmaceutical Review
APRIL 19, 2024
The paper reported that benefits of these alternative methodologies include “the ability to respond more quickly to adverse microbiological results, as well as leading to fewer waste products”. The post Microbial burden assessment of solid pharmaceutical products appeared first on European Pharmaceutical Review.
Let's personalize your content